Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg
Clinical trial NCT02952937 · COMPLETED
Trial details
- NCT number
- NCT02952937
- Sponsor
- GL Pharm Tech Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2016-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.